Navigation Links
Morphine Withdrawal Complicates Hepatitis C Infection in Drug Abusers

Hepatitis C, a condition that leads to inflammation of the liver is common among intravenous drug users. There are nearly 70-80 % of abusers are suffering from // the disease in the United States.

This high association has generated interest in determining the effects of drug abuse, specifically opiates, on progression of the disease. The discovery of such an association would impact treatment of both HCV infection and drug abuse. It has now been established from a recent study that morphine withdrawal complicates the Hepatitis C infection by suppressing IFN-alpha-mediated immunity and enhancing virus replication.

It has previously been shown using cell culture techniques that morphine enhances virus replication and inhibits IFN-alpha (a natural anti-viral factor produced by immune, as well as host cells, and the only one approved in recombinant form for treating HCV infection).

The researchers examined the effects of morphine withdrawal (MW) on HCV-infected cultured liver cells by exposing cells to the drug for four days followed by its removal. They also assessed the effects of using naloxone.

To measure HCV replication, they used a virus-like “replicon” that mimics the events that occur in liver cells. Although the replicon does not produce the infectious virus, the HCV replicon system represents the best available system for examining the impact of opiates on HCV at the time of the study.

It was found that there was an increase in the number of HCV replicon in both the withdrawal scenario. Furthermore, there was an inhibition of the IFN-alpha expression in liver cells in the presence or absence of HCV replicon in both the cases.

Since IFN-alpha is a critical self-defense mechanism utilized by liver cells to fight off viral infection, including HIV, this study suggests that morphine withdrawal weakens host cell immunity and provides a favorable environment for HCV growth in the liver. The s tudy also throws light on explaining why so many HCV-infected patients fail to respond to IFN-alpha treatment.

These results suggest that opioid abusers experiencing periods of drug abuse, followed by periods of withdrawal (due to lack of supplies) may lead to immunocompromised liver. The study also underscores the necessity of future clinical and epidemiological studies to define the role of opiate abuse in promoting HCV disease. These findings further support the need for methadone maintenance treatment as an additional benefit for opioid abusers.
'"/>




Related medicine news :

1. Morphine may excite cancerous tumors
2. Using Morphine to Hasten Death Is a Myth, Says Doctor
3. How Morphine Affects Memory
4. Withdrawal Notice Issued For Older Pacemakers Due To Malfunctioning of the Device
5. Hospital Services Still Paralysed Inspite Of The Withdrawal Of The Strike
6. Risk Of Death Increases With Sudden Withdrawal Of Medications
7. Sudden Opioid Withdrawal Results in ‘Broken Heart Syndrome
8. Cadbury Dismisses Rumors of Withdrawal of More Products
9. Andhra Wants Withdrawal of Warning Signal from ‘Beedi’ Packes
10. HIV Testing Improves After Withdrawal of Consent Letter
11. FDA Announces Voluntary Withdrawal of Pergolide Products
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/8/2019)... , ... October 08, 2019 , ... ... progression in live samples, Meiqing Shi, associate professor with the University of Maryland ... his latest paper published in Nature Communications, Shi and his lab have discovered ...
(Date:10/8/2019)... ANNAPOLIS, Md. (PRWEB) , ... October 08, 2019 , ... ... IV, metastatic breast cancer, announced the launch of its Stage IV Stampede campaign. The ... 11, 2019 in Washington, DC that will include an advocacy boot camp, a march, ...
(Date:10/8/2019)... , ... October 08, 2019 , ... ... biomimetic dentistry techniques, has recently attended an advanced Level III training in Cagliari, ... of dentistry. The training took place September 16-19, 2019 at the Sardinia Dental ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... Irving, Texas, that exclusively serves premier oral and maxillofacial surgeons – has formed ... maxillofacial surgery practice with two locations near Knoxville, Tennessee. The partnership is USOSM’s ...
(Date:10/8/2019)... ... October 08, 2019 , ... Continuing ... a new study showing that Care4U™ 2’-FL, a DuPont product, beneficially changes microbiota ... lactose. The effects elicited to microbiota and metabolite composition by 2’-FL were between ...
Breaking Medicine News(10 mins):
(Date:10/8/2019)... ... 2019 , ... Respected oral and maxillofacial surgeon, Dr. Brandon ... Surgery. This cutting-edge practice serves both Washington, PA and Steubenville, OH with the ... jaw surgery with 3D imaging. Dr. Humberger was honored to join Dr. Steven ...
(Date:10/8/2019)... ... , ... Fresno resident Regina Tanner has been selected by Donate Life ... will walk alongside the float, Light in the Darkness, during the 131st Tournament of ... a living organ donor in the fall of 2016 when her husband, Cary, was ...
(Date:10/8/2019)... ... October 08, 2019 , ... A free, interactive event highlighting ... in Austin, Texas. The event, featuring thought leaders, innovators and health experts, will display ... Held from 2:00 p.m. to 5:30 p.m. CT on October 19 at the Coppertank ...
Breaking Medicine Technology: